Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia
January 2009
Letter To Editor
volume 23, issue 3 pp 627-629.
| Related Files |
|---|
|
Redirect to publisher's version
(publisher's version.url.txt, 38 bytes) |
Repository contains one additional file which is not publicly available
Keywords
- adult
- article
- human
- male
- priority journal
- unclassified drug
- daunorubicin
- cyclophosphamide
- imatinib
- acute lymphoblastic leukemia
- methotrexate
- prednisone
- T cell leukemia
- cytogenetics
- BCR ABL protein
- fusion gene
- case report
- chronic myeloid leukemia
- dasatinib
- multiple cycle treatment
- vincristine
- NUP214 protein
- T lymphoblast
- absence of side effects
- asparaginase
- cancer regression
- cytarabine
- erythrocyte transfusion
- febrile neutropenia
- gene amplification
- fluorescence in situ hybridization
- lymphocytic infiltration
- mitoxantrone
- mucosa inflammation
- protein tyrosine kinase
- recombinant granulocyte colony stimulating factor
- thrombocyte transfusion
